PROZ / Switzerland / Research
Swiss research
Research groups across Switzerland working on psychedelic pharmacology, therapy, neuroscience, and public health.
Directory
Psychedelic research compendium
A guide to Swiss research groups, continuing the compendium created by the PROZ team. Links and group leads were checked in September 2026; follow each group for current details.
Center for Addiction Disorders
ZürichAddictive disorders, neuroimaging, neurophysiology, and epidemiology.
PD Dr. Marcus Herdener↗
Clinical Research Group for Substance-Assisted Therapy
BaselLong-term effects, LSD, and psychedelic-assisted therapy.
PD Dr. med. Felix Müller↗
Liechti Lab
BaselPsychopharmacology and pharmacokinetics, in vitro and in vivo.
Prof. Dr. Matthias Liechti↗
Molecular Psychiatry
FribourgNeuroscience, adverse effects, phenomenology, and psychedelic therapy.
Prof. Dr. Gregor Hasler↗
Pharmaco-Neuroimaging and Cognitive-Emotional Processing
ZürichEmotional and cognitive processes, neurobiology, and pharmacology.
PD Dr. Katrin Preller↗
Psychedelic Research & Therapy Development
ZürichPsychedelic therapy development and neuropsychopharmacology.
PD Dr. med. Milan Scheidegger↗
PSYCHE Project
LausanneCommunity-based participatory research, psychedelic-assisted psychotherapy, and knowledge translation.
Dr. Xavier Mabire↗
Soravia Group
BernPsychoneuroendocrinology, neuronal mechanisms, and psychedelic-assisted psychotherapy.
Prof. Dr. Leila Soravia & Prof. Dr. Tobias Bracht↗
University Hospital Geneva
GenevaPsychedelic-assisted therapy and psychotherapy research.
Prof. Dr. Daniele Zullino and colleagues↗Clinical information
Therapy resources
PROZ is an educational student association, not a treatment provider.